phenylalanylphenylalanylamide has been researched along with Allodynia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diwakarla, S; Fransson, R; Gaugaz, FZ; Hallberg, M; Jonsson, A; Karlgren, M; Lesniak, A; Nyberg, F; Sandström, A; Skogh, A; Sköld, C; Svensson, R | 1 |
Hallberg, M; Sandstrom, A | 1 |
Asato, M; Carlsson, A; Fransson, R; Hallberg, M; Kamei, J; Koizumi, T; Nakanishi, Y; Nyberg, F; Ohsawa, M; Sandström, A | 1 |
1 review(s) available for phenylalanylphenylalanylamide and Allodynia
Article | Year |
---|---|
From the Anti-Nociceptive Substance P Metabolite Substance P (1-7) to Small Peptidomimetics.
Topics: Analgesics; Animals; Binding Sites; Dipeptides; Humans; Hyperalgesia; Neuralgia; Oligopeptides; Peptide Fragments; Peptidomimetics; Protein Conformation; Structure-Activity Relationship; Substance P | 2018 |
2 other study(ies) available for phenylalanylphenylalanylamide and Allodynia
Article | Year |
---|---|
An imidazole based H-Phe-Phe-NH
Topics: Amides; Animals; Cell Death; Cell Survival; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Hyperalgesia; Imidazoles; Injections, Intraperitoneal; Mice; Molecular Structure; Peptidomimetics; Rats; Spinal Nerves | 2018 |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Dipeptides; Hyperalgesia; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Nociception; Pentazocine; Phosphorylation; Receptors, sigma; Reverse Transcriptase Polymerase Chain Reaction | 2011 |